Related references
Note: Only part of the references are listed.Facultative Sterol Uptake in an Ergosterol-Deficient Clinical Isolate of Candida glabrata Harboring a Missense Mutation in ERG11 and Exhibiting Cross-Resistance to Azoles and Amphotericin B
Claire M. Hull et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Amphotericin primarily kills yeast by simply binding ergosterol
Kaitlyn C. Gray et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A Clinical Isolate of Candida albicans with Mutations in ERG11 (Encoding Sterol 14α-Demethylase) and ERG5 (Encoding C22 Desaturase) Is Cross Resistant to Azoles and Amphotericin B
Claire M. Martel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Identification and Characterization of Four Azole-Resistant erg3 Mutants of Candida albicans
Claire M. Martel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
MUTANTS WITH HETERORESISTANCE TO AMPHOTERICIN B AND FLUCONAZOLE IN CANDIDA
A. L. R. Claudino et al.
BRAZILIAN JOURNAL OF MICROBIOLOGY (2009)
Gain of Function Mutations in CgPDR1 of Candida glabrata Not Only Mediate Antifungal Resistance but Also Enhance Virulence
Selene Ferrari et al.
PLOS PATHOGENS (2009)
A nonsense mutation in the ERG6 gene leads to reduced susceptibility to polyenes in a clinical isolate of Candida glabrata
Patrick Vandeputte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Identification of essential amino acid residues in a sterol 8,7-isomerase from Zea mays reveals functional homology and diversity with the isomerases of animal and fungal origin
Alain Rahier et al.
BIOCHEMICAL JOURNAL (2008)
Resistance to antifungal agents: Mechanisms and clinical impact
Zeina A. Kanafani et al.
CLINICAL INFECTIOUS DISEASES (2008)
Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth
Patrick Vandeputte et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts
F. Sabatelli et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Discovery of high-affinity ligands of σ1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening
C Laggner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance
M Sanguinetti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Candida glabrata erg1 mutant with increased sensitivity to azoles and to low oxygen tension
HF Tsai et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents
D Sanglard et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.
MA Pfaller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Non-albicans Candida spp. causing fungaemia:: pathogenicity and antifungal resistance
V Krcmery et al.
JOURNAL OF HOSPITAL INFECTION (2002)
Share Paper
